Dermatology Times, May 2019 (Vol. 40, No. 5)

Advancing women in aesthetics

May 14, 2019

Earlier this year, Galderma announced a new multi-disciplinary group of advisory members that compose The Women in Aesthetics Leadership Council. In this article, Dermatology Times acknowledges and congratulates the women on the advisory board who fall under the dermatology specialty.

More data needed to back SLNB for melanoma

May 14, 2019

Sentinel lymph node biopsy (SLNB) has classically been performed for regional disease control and to hopefully prevent disease metastasis; however, according to this expert, there has not been any good evidence to support this practice.

My new insight on eczema

May 10, 2019

Have you ever found yourself on the other side of the stethoscope? That’s what happened when Dr. Wheeland awoke one day with an asymptomatic, solitary, round, scaly patch on his ankle. Read how this experience inspired him to take a second look at how he treats patients with eczema.

My AI will see you now

May 10, 2019

Some might view the use of non-human intelligence in dermatology as a threat. But this expert believes it's up to dermatologists to transform this technology into an opportunity to ‘augment' clinical practice.

What you should know about technology transfer

May 10, 2019

In this month's Innovations column, Steve Xu, M.D., FAAD, begins the first part of a two-part mini-series discussing what innovators should know about intellectual property. This installment focuses on the different scenarios innovators may run into when dealing with the transfer of technological property, called technology transfer.

Facial care fleshed out

May 02, 2019

What is the medical value of disposable paper face masks? Is there an effective cosmetic treatment for black dot follicles? Dr. Zoe Diana Draelos answers these questions and more in this month's Cosmetic Conundrums column. 

Can I charge uninsured patients more?

April 30, 2019

It is common knowledge that both not-for-profit and for-profit hospitals across the U.S. have policies of charging uninsured patients more. And some physicians have done the same. But patients are starting to question these policies, landing some hospitals and physicians in hot water.

A game-changer for children with atopic dermatitis

April 26, 2019

“Pretty much, I couldn’t go about my normal life,” says Benjamin Sun about a life-altering eczema flare up at age 9, which left him out of school and bedridden for weeks. Until now, children like Sun didn’t have an effective, safe option for long-term disease control. Read how dupilumab changed his quality of life, and what it can do for your pediatric patients with uncontrolled moderate to severe atopic dermatitis.

Skin protection protocol

April 15, 2019

Derms don’t let other derms leave their office without SPF. Even more importantly, they shouldn’t ever let their post skin treatment patients leave without proper sun protection either.

Acne mechanica caused by skin on skin friction

April 08, 2019

Acne mechanica usually occurs when skin is pressed against heavy clothing or bulky protective gear, but dermatologists recently discovered a case of the condition caused by friction between the inner thighs of an obese teenager.

JAK inhibitors offer multiple applications

March 21, 2019

Unlike prior generations of dermatologic drugs, Janus kinase (JAK) inhibitors show potential for treating numerous dermatologic indications. Brett King, M.D., Ph.D. explored what this class of drug has to offer in his presentation during AAD earlier this month.

Immunotherapies for Staphylococcus aureus

March 21, 2019

Staphylococcus aureus infections are becoming more challenging to treat due to methicillin-resistant Staphylococcus aureus (MRSA). A better understanding of cutaneous immune mechanisms will identify specific immune mechanisms to target for future vaccines and immunotherapies to ultimately address this serious public health threat.

In-office Rx dispensing fills care gap

February 25, 2019

Although prescribers who provide in-office dispensing must satisfy applicable state and other requirements, a recent ruling against Allergan's attempt to shut down Prescriber's Choice appears to pave the way for expansion of these services, according to Wm. Philip Werschler, M.D.